Filter Results
:
(212)
Show Results For
- All HBS Web (212)
- Faculty Publications (139)
Show Results For
- All HBS Web (212)
- Faculty Publications (139)
- April 1991 (Revised November 1997)
- Case
Levi Strauss & Co. and the AIDS Crisis
Keywords:
Health Disorders;
Employee Relationship Management;
Corporate Social Responsibility and Impact;
Apparel and Accessories Industry
Tedlow, Richard S. "Levi Strauss & Co. and the AIDS Crisis." Harvard Business School Case 391-198, April 1991. (Revised November 1997.)
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process....
View Details
Keywords:
Drug Development;
Drug Discovery;
Drug Trials;
Pharmaceutical Companies;
Pharmaceutical Company;
Pharmaceuticals;
Therapeutics;
Biologics;
Biotech;
Biotechnology;
Biopharmacy Company;
Biochemistry;
Technology Commercialization;
Technology Companies;
Drug Testing;
Startup;
Start-up;
Startups;
Start-ups;
Startup Financing;
Strategic Decision Making;
Strategic Decisions;
Strategic Evolution;
FDA;
Food And Drug Administration;
Clinical Trials;
Disease Management;
Market Attractiveness;
Market Entry;
Market Opportunities;
Health Disorders;
Technological Innovation;
Information Technology;
Commercialization;
Business Startups;
Finance;
Decision Making;
Strategy;
Market Entry and Exit;
Opportunities;
Pharmaceutical Industry;
Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- 01 Sep 2010
- News
RX for Change
employs 9,000 people and ranks as Georgia’s largest, most comprehensive health system. Under consideration this day is a proposal to add specialists — known as neurohospitalists — to manage care for patients with View Details
- August 2010 (Revised January 2013)
- Case
Avi Kremer
By: Joshua D. Margolis and Mark Wetzel
If you were diagnosed with a terminal illness, how would you respond and what would you do with your remaining time? Avi Kremer contemplates four options for how to devote himself 18 months after being diagnosed with ALS. His experience thus far and the choices he...
View Details
Keywords:
Entrepreneurship;
Values and Beliefs;
Health Disorders;
Leadership Development;
Personal Development and Career;
Social Enterprise;
Personal Characteristics
Margolis, Joshua D., and Mark Wetzel. "Avi Kremer." Harvard Business School Case 411-022, August 2010. (Revised January 2013.)
- Article
Putting Patients First: Social Marketing Strategies for Treating HIV in Developing Nations
By: Zoe Chance and Rohit Deshpandé
It is more than mere coincidence that the highest rates of HIV occur in the world's poorest countries. Of the over 40 million people currently living with HIV, 95 percent are in the developing world. The first part of this paper explores the economics of HIV and...
View Details
Keywords:
Health Disorders;
Developing Countries and Economies;
Poverty;
Health Care and Treatment;
Social Marketing;
Perspective;
Customer Focus and Relationships;
Profit;
Africa;
Asia;
South America
Chance, Zoe, and Rohit Deshpandé. "Putting Patients First: Social Marketing Strategies for Treating HIV in Developing Nations." Special Issue on Metric and Interpretive Explorations of Macromarketing. Journal of Macromarketing 29, no. 3 (September 2009).
- August 2008 (Revised September 2008)
- Case
The Flaxil Label (A)
This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite...
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Health Disorders;
Product Launch;
Negotiation Process;
Business and Government Relations;
Safety;
Pharmaceutical Industry
Barron, Greg M. "The Flaxil Label (A)." Harvard Business School Case 909-001, August 2008. (Revised September 2008.)
- 23 Jan 2019
- News
The Promise of Personalized Medicine
Subscribe on iTunes Subscribe on SoundCloud More Skydeck episodes As a little kid, Rich Horgan (MBA 2018) doesn’t remember thinking much about the differences between himself and his younger brother, Terry. But as he started to get older, he started to ask questions:...
View Details
- February 2006 (Revised February 2009)
- Case
AIDS in Brazil
By: Rohit Deshpande and Ricardo Reisen de Pinho
Abbott Labs has reached an impasse with the Brazilian government in negotiations over the pricing of a new anti-AIDS drug, Kaletra. The Brazilian government threatens compulsory licensing unless Abbott drastically reduces the price of Kaletra.
View Details
Keywords:
Price;
Government and Politics;
Health Care and Treatment;
Health Disorders;
Rights;
Negotiation;
Business and Government Relations;
Pharmaceutical Industry;
Brazil
Deshpande, Rohit, and Ricardo Reisen de Pinho. "AIDS in Brazil." Harvard Business School Case 506-062, February 2006. (Revised February 2009.)
- June 2011
- Teaching Note
PatientsLikeMe: An Online Community of Patients (TN)
By: Sunil Gupta and Jason Riis
Teaching Note for 511093.
View Details
- January 2023
- Supplement
The END Fund (B)
By: V. Kasturi Rangan and Courtney Han
Founded in 2012, the END fund focused on eliminating five Neglected Tropical Diseases that accounted for 80% of the tropical diseases affecting nearly 1.5 billion people worldwide. Its roughly $25 million/year annual budget was fully committed when it got news that the...
View Details
Keywords:
Health Disorders;
Investment Funds;
Global Range;
Nonprofit Organizations;
Resource Allocation;
Decisions;
Health Care and Treatment;
Mission and Purpose
Rangan, V. Kasturi, and Courtney Han. "The END Fund (B)." Harvard Business School Supplement 523-064, January 2023.
- May 2016 (Revised March 2020)
- Teaching Note
Cyberdyne: A Leap to the Future
By: Doug J. Chung and Mayuka Yamazaki
Cyberdyne Inc. was a Japanese technology venture founded in 2004 by scientist Yoshiyuki Sankai to commercialize a hybrid assistive limb (HAL). HAL was a robotic exoskeleton system for people who had difficulty walking due to nervous system disabilities resulting from...
View Details
- 11 Jul 2013
- News
Making Lives Better
Autism Science Foundation, which she founded in 2009, was a result of Tepper Singer's passion to fuel scientific research. To that end, ASF, which is based in New York City, funds pre- and post-doctorate fellowships for young scientists who can use the data to apply...
View Details
- December 2012 (Revised November 2014)
- Case
W.R. Grace & Co.: Dealing with Asbestos Torts
By: Stuart C. Gilson and Sarah L. Abbott
A manufacturer of building products and specialty chemicals, W. R. Grace & Co. filed for Chapter 11 bankruptcy in 2001 in response to a flood of lawsuits alleging that its products contained asbestos, and had caused hundreds of thousands of people to contract...
View Details
Keywords:
Bankruptcy Reorganization;
Business Failures;
Environmental Regulations;
Class Action Lawsuits;
Natural Environment;
Valuation;
Health Disorders;
Capital Structure;
Restructuring;
Lawsuits and Litigation;
Chemicals;
Crisis Management;
Insolvency and Bankruptcy;
Legal Liability;
Construction Industry;
Chemical Industry;
United States
Gilson, Stuart C., and Sarah L. Abbott. "W.R. Grace & Co.: Dealing with Asbestos Torts." Harvard Business School Case 213-046, December 2012. (Revised November 2014.)
- December 1993 (Revised November 2009)
- Case
Manville Corporation Fiber Glass Group (A)
By: Lynn S. Paine and Sarah Gant
Manville Corp.'s senior managers must decide how to respond to a new scientific study suggesting that fiberglass, the source of 75% of the company's profits, may be another asbestos and must act under conditions of great uncertainty. In particular, when should a...
View Details
Keywords:
Communication Strategy;
Decision Choices and Conditions;
Ethics;
Health Disorders;
Risk Management;
Marketing Communications;
Product;
Corporate Social Responsibility and Impact;
Safety;
Consumer Products Industry;
Industrial Products Industry
Paine, Lynn S., and Sarah Gant. "Manville Corporation Fiber Glass Group (A)." Harvard Business School Case 394-117, December 1993. (Revised November 2009.)
- 26 Mar 2013
- News
Ex-Washington Governor Dies at 76
- 16 May 2017
- First Look
First Look at New Ideas and Research, May 16
May–June 2017 Harvard Business Review Neurodiversity as a Competitive Advantage By: Austin, Robert D., and Gary P. Pisano Abstract—Many people with neurological conditions such as autism spectrum disorder and dyslexia have extraordinary...
View Details
Keywords:
Re: Multiple Faculty
- 01 Dec 2009
- News
Seven Honored with Alumni Achievement Award
On October 19, the School conferred its highest honor, the Alumni Achievement Award, on seven distinguished individuals. Since 1968, the School has selected outstanding men and women for the award, recognizing their accomplishments in the public and the private...
View Details
- 01 Dec 2011
- News
Making the Case for Leadership
Angeles–based dialysis provider TRC. Thiry (MBA 1983) had just completed a difficult, ultimately unsuccessful term as CEO of another health care organization. After that experience, he pledged to join his wife, Denise O’Leary (also MBA...
View Details
Keywords:
Garry Emmons;Julia Hanna;Roger Thompson;
Performing Arts, Spectator Sports, and Related Industries;
Arts, Entertainment;
National Security and International Affairs;
Government;
Health, Social Assistance;
Data Processing, Hosting, and Related Services;
Information;
Electrical Equipment, Appliance, and Component Manufacturing;
Manufacturing;
Food Manufacturing;
Manufacturing;
Nonmetallic Mineral Product Manufacturing;
Manufacturing;
Management, Scientific, and Technical Consulting Services;
Professional Services
- 01 Dec 2010
- News
This Is What I Do
Katie Hood: Fast Forward Hood Hood and Fox In the hit movie Back to the Future, actor Michael J. Fox plays Marty McFly, a teenager in a hurry. Accidentally sent backward through time, Marty encounters a slew of nasty complications. (One of his main concerns is eluding...
View Details